
Open Offer4 Jul 2026, 09:30 am
Colinz Laboratories: Open Offer for 26% Stake at ₹54/Share
AI Summary
Saffron Capital Advisors Pvt Ltd, acting as the Manager to the Open Offer, has submitted a Draft Letter of Offer (DLOF) to BSE. The open offer is being made by Antariksh Dugar (Acquirer 3), along with Annjana Dugar (Acquirer 1), Likhitta Dugar (Acquirer 2), and Padam Dugar (PAC), to acquire up to 6,54,966 equity shares of Colinz Laboratories Ltd. This represents 26% of the voting share capital. The offer price is ₹54 per equity share, valuing the total acquisition at ₹3,53,68,164. The offer is being made pursuant to SEBI (SAST) Regulations, 2011, for substantial acquisition of shares and voting rights accompanied by a change in control, and is not conditional on minimum acceptance.
Key Highlights
- Open offer to acquire 26% of Colinz Laboratories' voting share capital.
- Offer price set at ₹54 per equity share.
- Total acquisition value amounts to ₹3,53,68,164.
- Acquisition involves a change in control, as per SEBI regulations.
- Offer is not conditional on minimum acceptance levels.
Price Impact
More from COLINZ